Is this you? Create Your Porfile
Avatar

Van Pel Aline

Ludwig Institute for Cancer Research

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Van Pel Aline is active.

Explore More

Publication

Featured researches published by Van Pel Aline.

Archive | 2009

VON MAGE-10 ODER MAGE-8 ABGELEITETE HLA-A2.1- BINDENDE OLIGOPEPTIDE

Huang Lan-Qing; Van Pel Aline; Brasseur Francis; De Plaen Etienne; Boon Thierry

Archive | 2006

Kasvaimen hyljintäantigeenin esiasteet, kasvaimen hyljintäantigeenit ja niiden käytöt

Boon Thierry; Van Der Bruggen Pierre; Van Den Eynde Benoit; Van Pel Aline; De Plaen Etienne; Lurquin Christophe; Chomez Patrick; Traversari Catia

Archive | 2005

PRECURSORES DE ANTIGENOS DE RECHAZO TUMORAL, ANTIGENOS DE RECHAZO TUMORAL Y SUS USOS.

Boon Thierry; Van Der Bruggen Pierre; Van Den Eynde Benoit; Van Pel Aline; De Plaen Etienne; Lurquin Christophe

Archive | 2001

Use of isolated tyrosinase derived peptides in treating cellular abnormality

Lethe Bernard; Brichard Vincent; Van Pel Aline; Boon-Falleur Thierry; Woelfel Thomas

Archive | 2001

Use of tumour rejection antigen precursor antigen HLA-A2 complexes to treat cancers

Brichard Vincent; Van Pel Aline; Coulie Pierre; Boon-Falleur Thierry; De Plaen Etienne; Traversari Catia; Wolfel Thomas

Archive | 2001

METODOS PARA LA DETECCION Y EL TRATAMIENTO DE INDIVIDUOS CON CELULAS ANORMALES QUE EXPRESAN ANTIGENOS PEPTIDOS HLA-A2/TIROSINASA.

Boon-Falleur Thierry; Brichard Vincent; Van Pel Aline; De Plaen Etienne; Coulie Pierre; Renauld Jean-Christophe

Archive | 2000

Brain glycogen phosphorylase tumour rejection antigen precursors including antibodies to and nucleic acids coding them also methods and products for diagnosing and treating conditions characterised by expression of a BGPTR antigen or precursor thereof

Brichard Vincent; Van Pel Aline; Boon-Falleur Thierry; Gorin Frederic A

Archive | 2000

Fremgangsmåder til påvisning og behandling af individer, som har unormale celler, som udtrykker HLC-A2/tyrosinasepeptid-antigener

Boon-Falleur Thierry; Brichard Vincent; Van Pel Aline; De Plaen Etienne; Coulie Pierre; Renault Jean-Christophe; Woelfel Thomas; Lethe Bernard

Archive | 1999

TREATMENT OF HUMAN CELLULAR ABNORMALITY BY PROVOKING CYTOLYTIC T CELL RESPONSE TO CELLS PRESENTING COMPLEXES OF AN MHC MOLECULE AND A TYROSINASE DERIVED PEPTIDE ON THEIR SURFACES

Woelfel Thomas; Van Pel Aline; Brichard Vincent; Boon-Falleur Thierry

Archive | 1998

IDENTIFYING COMPLEXES OF MHC (ESP HLA) MOLECULES AND TYROSINASE DERIVED PEPTIDES ON ABNORMAL CELL SURFACES

Woelfel Thomas; Van Pel Aline; Brichard Vincent; Boon-Falleur Thierry

Explore More

Collaboration

Dive into the Van Pel Aline's collaboration.

Top Co-Authors
Avatar

De Plaen Etienne

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Boon-Falleur Thierry

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Brichard Vincent

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Traversari Catia

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Woelfel Thomas

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Coulie Pierre

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Van Der Bruggen Pierre

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Lethe Bernard

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Lurquin Christophe

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors
Avatar

Renauld Jean-Christophe

Ludwig Institute for Cancer Research

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge